Gene Therapies
Gene therapies have the potential to restore lost functions, extend human lifespans, and revolutionize regenerative medicine. I am particularly interested in therapies aimed at restoring sight, such as retinal regeneration and optic nerve repair, which could provide life-changing treatments for blindness and vision impairments. Additionally, telomere lengthening holds promise in slowing aging and extending lifespan, potentially mitigating age-related diseases and enhancing longevity.
Gene therapy also plays a crucial role in bioprinting and regenerative medicine, where genetic modifications can improve host acceptance of lab-grown organs and tissues. By reducing immune rejection and enhancing cellular integration, these advancements could make organ transplants safer, more effective, and widely available. As the field progresses, these technologies have the potential to reshape medicine, offering curative rather than palliative solutions to many conditions.
My professional ambitions
I aim to contribute to the advancement of gene therapies that restore function, enhance longevity, and improve regenerative medicine. My focus is on how genetic innovations can be applied to vision restoration, telomere extension, and organ transplantation, ensuring these technologies scale responsibly to become more accessible and widely adopted.
By working at the intersection of biotechnology, regenerative medicine, and healthcare policy, I hope to play a role in ensuring that gene therapies are both cutting-edge and ethically implemented, paving the way for a future where genetic treatments enhance human health and longevity.
Primary Interests
- Sight restoration
- Role in bioprinted organs
- Lengthening telomeres
- Permament fixes